1 July 2010: Mandatory notification [...]

The following primary insiders in NorDiag ASA have today exercised Class B Warrants:

Robert V. Ahlgren, Chairman of the Board in NorDiag ASA, has exercised 18,000 Class B Warrants to purchase 60,898 shares in NorDiag at the subscription price of NOK 2.18 per share. New holding of NorDiag shares after the transaction is 222,394.

Hans Hekland, Vice Chairman of the Board in NorDiag ASA, has exercised through his wholly owned investment company Hannibal Invest 23,981 Class B Warrants to purchase 81,133 shares in NorDiag at the subscription price of NOK 2.18 per share. New holding of NorDiag shares after the transaction is 572,137.

Tone Kvåle, CFO in NorDiag ASA, has exercised 5,625 Class B Warrants to purchase 19,030 shares in NorDiag at the subscription price of NOK 2.18 per share. New holding of NorDiag shares after the transaction is 156,732.

Dagfinn Øgreid, Medical Director in NorDiag ASA, has through his wholly owned company Colon AS exercised 50,000 Class B Warrants to purchase 169,161 shares in NorDiag at the subscription price of NOK 2.18 per share. New holding of NorDiag shares after the transaction is 915,579.

Contact: CEO Mårten Wigstøl Phone. +47 911 65775